文献速递胸部肿瘤支持与姑息治疗

阿米万他单抗致毛细血管渗漏综合征经静脉免疫球蛋白成功治疗一例

Amivantamab-Induced Capillary Leak Syndrome Successfully Treated With Intravenous Immunoglobulin Administration: Case Report.
PubMed 文献 · J Thorac Oncol · 2026-10-29

本文报告一例转移性非小细胞肺癌患者在接受阿米万他单抗治疗后发生毛细血管渗漏综合征(CLS),表现为全身水肿、低血压和低白蛋白血症。停用阿米万他单抗并短期给予大剂量静脉免疫球蛋白后CLS缓解,提示静脉免疫球蛋白可能对阿米万他单抗诱导的CLS有效。

要点

  • 阿米万他单抗治疗中需警惕毛细血管渗漏综合征,尽管既往仅报告外周水肿。
  • 阿米万他单抗相关CLS在停药并短期大剂量静脉免疫球蛋白治疗后缓解。
  • 静脉免疫球蛋白的抗炎、中和及加速抗体清除作用可能解释其疗效。

核心结论

  • 阿米万他单抗可导致毛细血管渗漏综合征,停药并短期大剂量静脉免疫球蛋白治疗后可缓解。

研究设计与样本

  • 个案报道,描述一例接受阿米万他单抗治疗的转移性非小细胞肺癌患者发生CLS。

主要发现

  • 患者出现全身水肿、低血压和低白蛋白血症,符合毛细血管渗漏综合征。
  • 停用阿米万他单抗并给予短期大剂量静脉免疫球蛋白后CLS缓解。

临床怎么用

  • 使用阿米万他单抗时需监测毛细血管渗漏综合征相关表现,疑似病例应停药并考虑静脉免疫球蛋白治疗。

局限性

  • 仅为单个病例报告,无法确立因果关系或推广至所有接受阿米万他单抗治疗的患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Capillary leak syndrome (CLS) is a rare but potentially life-threatening condition characterized by generalized edema, hypotension, and hypoalbuminemia. Amivantamab has recently been approved for the management of metastatic NSCLC. Although peripheral edema has been reported with amivantamab, CLS has not previously been described in association with this treatment. Herein, we report a case of CLS attributed to amivantamab that resolved after drug discontinuation and a short course of high-dose intravenous immunoglobulin administration. The anti-inflammatory, neutralizing, and antibody clearance-accelerating effects of intravenous immunoglobulin may explain their potential efficacy in treating amivantamab-induced CLS. As therapeutic antibodies become increasingly used, CLS may be encountered more frequently. A better understanding of its pathophysiologic characteristics is therefore essential to develop effective treatments and preventive strategies, ultimately minimizing its consequences on patient outcomes.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Lacroix T, Planchard D, Kasraoui I, et al. Amivantamab-Induced Capillary Leak Syndrome Successfully Treated With Intravenous Immunoglobulin Administration: Case Report. J Thorac Oncol. 2026. PMID: 42961384. doi:10.1016/j.jtho.2026.106136

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。